Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Abbott India Q4FY20 performance hit by COVID 19 impact: ICICI Securities

expresspharmaJune 10, 2020

Tag: Abbott , COVID-19 , EBITDA , Q4FY20

PharmaSources Customer Service